AU2001283539A1 - Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists - Google Patents

Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists

Info

Publication number
AU2001283539A1
AU2001283539A1 AU2001283539A AU8353901A AU2001283539A1 AU 2001283539 A1 AU2001283539 A1 AU 2001283539A1 AU 2001283539 A AU2001283539 A AU 2001283539A AU 8353901 A AU8353901 A AU 8353901A AU 2001283539 A1 AU2001283539 A1 AU 2001283539A1
Authority
AU
Australia
Prior art keywords
alkoxyguanidines
tetrahydroisoquinoline
carboxylic acid
integrin antagonists
integrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283539A
Inventor
Aihua Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3 Dimensional Pharmaceuticals Inc
Original Assignee
3 Dimensional Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 Dimensional Pharmaceuticals Inc filed Critical 3 Dimensional Pharmaceuticals Inc
Publication of AU2001283539A1 publication Critical patent/AU2001283539A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001283539A 2000-08-07 2001-08-07 Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists Abandoned AU2001283539A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22347800P 2000-08-07 2000-08-07
US60223478 2000-08-07
PCT/US2001/041601 WO2002012193A1 (en) 2000-08-07 2001-08-07 Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists

Publications (1)

Publication Number Publication Date
AU2001283539A1 true AU2001283539A1 (en) 2002-02-18

Family

ID=22836666

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283539A Abandoned AU2001283539A1 (en) 2000-08-07 2001-08-07 Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists

Country Status (3)

Country Link
US (1) US20020037897A1 (en)
AU (1) AU2001283539A1 (en)
WO (1) WO2002012193A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0209711A (en) 2001-05-29 2004-11-03 Kyoto Pharma Ind Heterocyclic compound and its medicinal use
MXPA03010867A (en) 2001-05-29 2004-02-27 Kyoto Pharma Ind Novel heterocyclic derivatives and medicinal use thereof.
US20070077303A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
PT2054045E (en) * 2006-08-16 2011-08-31 Action Medicines Sl Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain
JP6425712B2 (en) 2013-05-14 2018-11-21 ザ ルブリゾル コーポレイションThe Lubrizol Corporation Lubricating composition and method of lubricating a transmission

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731324A (en) * 1993-07-22 1998-03-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
DE19548709A1 (en) * 1995-12-23 1997-07-03 Merck Patent Gmbh Tyrosine derivatives
AU3343097A (en) * 1996-06-28 1998-01-21 Merck Patent Gmbh Phenylalamine derivatives as integrin inhibitors
CA2309341A1 (en) * 1997-11-24 1999-06-03 Merck & Co., Inc. Substituted .beta.-alanine derivatives as cell adhesion inhibitors
JP2001524467A (en) * 1997-11-26 2001-12-04 3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド Heteroarylaminoguanidines and alkoxyguanidines and their use as protease inhibitors
US6344486B1 (en) * 1998-04-03 2002-02-05 3-Dimensional Pharmaceuticals, Inc. Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
JP2003501352A (en) * 1999-05-27 2003-01-14 3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド Oxaza heterocycles as protease inhibitors

Also Published As

Publication number Publication date
US20020037897A1 (en) 2002-03-28
WO2002012193A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU2001269876A1 (en) Heteroarylalkanoic acids as integrin receptor antagonists
AU3213799A (en) Integrin antagonists
AU7315800A (en) Mch antagonists
AU3157801A (en) Beta-amino acid compounds as integrin antagonists
AU2001210928A1 (en) Polypropylene card construction
EP1206262A4 (en) Npy antagonists: spiroisoquinolinone derivatives
IL154053A0 (en) AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS alpha4 INTEGRIN ANTAGONISTS
EP1130098A3 (en) Mammalian osteoregulins
AU2002235224A1 (en) Muscarinic antagonists
AU2001288040A1 (en) Homeostasis-maintaining agents
AU5991699A (en) Quinolizinones as integrin inhibitors
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001234741A1 (en) Integrin antagonists
AU2001231730A1 (en) Piperidyl carboxylic acids as integrin antagonists
AU2001280135A1 (en) Fibrinogen lowering agents
AU2541000A (en) Beta-phenylalanine derivatives as integrin antagonists
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU2765401A (en) Vial coupler
AU2002220598A1 (en) Beta-amino acid derivatives as integrin receptor antagonists
AU6221201A (en) Propanoic acid derivatives as integrin receptor antagonists
AU2001293131A1 (en) Hydroxy acid integrin antagonists
AU2673201A (en) Alpha-arylethylpiperazine derivatives as neurokinin antagonists
AU2001283539A1 (en) Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
AU2001271018A1 (en) Gpr14 antagonist
AU2002218903A1 (en) Modified container